Evidence map›Paper›PMID 39430781›Full record

ArticleMethodsX2024

Combined fluorometric analysis of biliverdin and bilirubin by the recombinant protein HUG.

Federica Tramer, Paola Sist, Rocio Cardenas-Perez, Ranieri Urbani, Giulia Bortolussi, Sabina Passamonti

Abstract read
In one paragraph

Article in MethodsX, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Federica TramerDepartment of Life Sciences, University of Trieste, via Giorgieri 1, I-34127, Trieste, Italy.
Paola SistDepartment of Life Sciences, University of Trieste, via Giorgieri 1, I-34127, Trieste, Italy.
Rocio Cardenas-PerezDepartment of Life Sciences, University of Trieste, via Giorgieri 1, I-34127, Trieste, Italy.
Ranieri UrbaniDepartment of Chemical and Pharmaceutical Sciences, University of Trieste, via Giorgieri 1, I-34127, Trieste, Italy.
Giulia BortolussiInternational Centre for Genetic Engineering and Biotechnology, 34149 Trieste, Italy.
Sabina PassamontiDepartment of Life Sciences, University of Trieste, via Giorgieri 1, I-34127, Trieste, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biliverdin is a secondary metabolite of heme catabolism. It is formed by the reaction catalyzed by heme oxygenase, which converts the heme group contained in proteins such as hemoglobin, myoglobin, cytochromes, and catalase into biliverdin, iron (II) and CO in equimolar amounts, consuming NADPH. Biliverdin is then reduced to bilirubin by biliverdin reductase. Biliverdin and bilirubin form a redox couple and are important for the redox homeostasis of cells. Heme oxygenase-1 is an inducible enzyme that is induced by hypoxic conditions, increased availability of heme or proinflammatory mechanisms such as LPS, UV radiation, etc. In addition, both heme oxygenase-1 and biliverdin reductase play roles other than catalysis by modulating specific metabolic pathways at the transcriptional level. There is a need for affordable assays to analyze these bile pigments in biological and clinical samples. Here we present a method for the combined determination of biliverdin and bilirubin that utilizes the specific binding of bilirubin to the fluorescent recombinant fusion protein HUG and the enzymatic conversion of biliverdin to bilirubin.•This method enables the combined measurement of bilirubin and biliverdin in the nM range.•The method does not require solvent extraction or protein precipitation of the samples.

Indexed as

Assay optimal parametersBiliverdinBiological fluidsCombined biliverdin and bilirubin analysis with HUGPlasma

Identifiers

PMID39430781
PMCPMC11490793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.